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Aims: To assess the reliability of mortality risk assessment using the Paediatric Risk of Mortality (PRISM)
score and the Paediatric Index of Mortality (PIM) in daily practice.
Methods: Twenty seven physicians from eight tertiary paediatric intensive care units (PICUs) were asked to
assess the severity of illness of 10 representative patients using the PRISM and PIM scores. Physicians were
divided into three levels of experience: intensivists (.3 years PICU experience, n = 12), PICU fellows (6–
30 months of PICU experience, n = 6), and residents (,6 months PICU experience, n = 9). This represents
all large PICUs and about half of the paediatric intensivists and PICU fellows working in the Netherlands.
Results: Individual scores and predicted mortality risks for each patient varied widely. For PRISM scores the
average intraclass correlation (ICC) was 0.51 (range 0.32–0.78), and the average kappa score 0.6
(range 0.28–0.87). For PIM scores the average ICC was 0.18 (range 0.08–0.46) and the average kappa
score 0.53 (range 0.32–0.88). This variability occurred in both experienced and inexperienced
physicians. The percentage of exact agreement ranged from 30% to 82% for PRISM scores and from 28 to
84% for PIM scores.
Conclusion: In daily practice severity of illness scoring using the PRISM and PIM risk adjustment systems is
associated with wide variability. These differences could not be explained by the physician’s level of
experience. Reliable assessment of PRISM and PIM scores requires rigorous specific training and strict
adherence to guidelines. Consequently, assessment should probably be performed by a limited number of
well trained professionals.
S
coring systems such as the Paediatric Risk of Mortality
(PRISM) score and Paediatric Index of Mortality (PIM)
are widely used in paediatric intensive care. These are
third generation scoring systems that allow assessment of the
severity of illness and mortality risk adjustment in hetero-
geneous groups of patients in an objective manner, enabling
conversion of these numbers into a numerical mortality risk
based on logistic regression analysis. The purpose of their
usage varies, and may include comparison of severity of
illness between different treatment arms in clinical trials and
comparison of quality of care between paediatric intensive
care units (PICUs) using standardised (that is, severity of
illness adjusted) mortality rates. Both the PRISM and PIM
scoring system have been developed and carefully validated
in tertiary PICUs.1–3 In some centres that were closely
involved in developing these scoring systems, preliminary
data have indicated that the degree of inter-observer
reliability was acceptable.4 5 As was the case in these centres,
patients are preferably scored by a small and dedicated
number of thoroughly trained professionals (for example,
research nurses). In principle, this form of organisation can
be expected to have a high inter-observer agreement.
However, the practical situation in numerous ICUs and
PICUs throughout Europe is that severity scoring is
performed by a varying number of residents, fellows,
(paediatric) intensivists, paediatricians, or nurses, with
varying degrees of PICU experience and training with the
PRISM and PIM score. This may imply that these scoring
systems will not achieve the same degree of accuracy and
reliability in everyday clinical practice.
We previously showed significant degrees of inter-observer
and intra-observer variability in the use of the APACHE II
scoring system, both in the research setting and in everyday
clinical practice.7–11 To our knowledge no studies have been
carried out to systematically address this issue in paediatric
ICUs. We therefore decided to assess the accuracy and
reliability of PRISM and PIM scoring in everyday clinical
practice, stratified by level of experience.
METHODS
Physicians from eight academic paediatric ICUs (tertiary
referral centres) with residency and fellowship training
programmes were asked to participate in our study.
Physicians were divided into three categories: residents
(n=9) with limited experience in paediatric intensive care
(average 3 months, range 6 weeks–6 months); PICU fellows
(n=6, average experience 18 months, range 6–30 months),
and paediatric intensivists (n=12) with at least three years
of full time PICU experience. For the Dutch situation this
means that all major paediatric centres were represented, and
that around 50% of all paediatric intensivists and PICU
fellows participated in our study.
The charts of 10 patients that had been admitted to a single
PICU in the course of a one year period were selected for
scoring. The charts were selected to reflect typical PICU
patients, and were not chosen for difficulty of scoring.
Relevant data from the medical charts and copies of blank
data collection sheets from the PRISM and PIM scores were
provided to all participating physicians. No specific additional
instructions were given to those who scored the patients, and
no time limit was given in order to mimic the routine
working situation as closely as possible. All physicians
assessed PRISM and PIM scores, which were noted on
similar data collection sheets as are used for routine
assessment. Mean (SD) and range of the PRISM and PIM
scores were calculated for each individual patient for the
Abbreviations: ICC, intraclass correlation; ICU, intensive care unit;
PICU, paediatric intensive care unit; PIM, Paediatric Index of Mortality;
PRISM, Paediatric Risk of Mortality
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overall group of physicians and for each of the three
categories of physicians, according to methods described
previously.8 Weighted kappa scores and intraclass correla-
tions (ICC) were also determined to assess inter-observer
agreement. A deviation of ¡1 point (PRISM score) or ¡1
item (PIM score) was designated as mild disagreement, ¡2
or 3 points (items) as moderate disagreement, and .3 points
(items) as severe disagreement. Statistical analysis was
performed using Student’s t test for unpaired variables for
paired groups and by analysis of variance (ANOVA).
Statistical significance was accepted for p , 0.05. Excel
(Microsoft Inc.) and SPSS 9.0 (SPSS Inc.) software was used
to perform the necessary calculations.
RESULTS
Tables 1–3 present the results. Table 1 depicts overall inter-
observer agreement as the percentage of exact agreement,
kappa scores, and ICC for the PRISM and PIM based
mortality risks, respectively. Tables 2 and 3 show the inter-
observer agreement for the PRISM and PIM score derived
mortality risk.
As is evident from the tables, a wide variation in both
PRISM and PIM based mortality risk assessment was found,
regardless of the level of expertise. Indeed, the differences
between the three groups were small, with statistically
significant differences observed only between residents and
intensivists for the PRISM based mortality risk (p , 0.01),
and for intensivists versus fellows and residents versus
fellows for the PIM based mortality risk (p , 0.05).
On analysis, the most frequent problems and sources of
error in determining PRISM scores were:
N The PaO2/FiO2 determination. An arterial PaO2 and a
measured FiO2 are mandatory, so it is only possible to
include this measurement if oxygen is given through an
endotracheal tube or by a blender, or when FiO2 is
measured by a ‘‘head’’ or ‘‘Gardner’’ box. In the absence of
an arterial PaO2, the score should be missing.
N Assessing the Glasgow Coma Score (GCS) when sedatives
have been given. It is only permitted to assess GCS before
administration of sedatives or after their effect has worn
off.
N In some observers there were difficulties in determining
the appropriate time window for PRISM calculation. This
should include the worst values in the first 24 hours after
PICU admission; patients admitted for less than 2 hours
should be excluded from scoring.1–3
The most frequent problems in determining PIM scores were:
N PIM scores should be determined by taking the first value
(instead of inappropriately using the worst value) during
the first hour after starting intensive care treatment. This
treatment may start outside the PICU, for example, in the
emergency room, by a retrieval service or a trauma team,
so that (in contrast to PRISM scores) in some cases values
obtained before PICU admission can be used to assess PIM
scores.
N Misinterpretation of underlying conditions. For example,
cardiac failure during sepsis was inappropriately scored as
cardiomyopathy, and muscular dystrophia was inappro-
priately counted as a neurodegenerative illness.
N Use of an FiO2 value measured at a different moment than
PaO2.
N Adequate definition of a booked admission to the ICU: this
should be a pre-arranged admission, for example after
elective surgery.
Table 1 Overall inter-observer agreement of PRISM score based mortality risk (%) and PIM score based mortality risk (%)
PRISM score based mortality risk* PIM score based mortality risk
Mean (SD) EA k scores (95% CI) Mean (SD) EA k scores (95% CI)
Patient 1 4.7 (6.9) 30 0.57 (0.51 to 0.64) 9.7 (8.8) 28 0.37 (0.28 to 0.45)
Patient 2 33.0 (27.4) 42 0.42 (0.35 to 0.50) 2.1 (2.0) 32 0.32 (0.20 to 0.44)
Patient 3 0.6 (0.3) 69 0.68 (0.62 to 0.76) 1.3 (1.3) 64 0.60 (0.54 to 0.65)
Patient 4 2.7 (2.4) 32 0.58 (0.50 to 0.64 7.0 (9.1) 24 0.37 (0.31 to 0.42)
Patient 5 0.5 (0.3) 52 0.61 (0.57 to 0.66) 2.7 (1.8) 64 0.56 (0.48 to 0.65)
Patient 6 1.8 (0.5) 82 0.84 (0.80 to 0.88) 4.8 (3.1) 84 0.88 (0.81 to 0.94)
Patient 7 3.2 (2.1) 33 0.28 (0.21 to 0.35) 6.8 (4.5) 40 0.36 (0.32 to 0.41)
Patient 8 17.2 (14.0) 41 0.63 (0.58 to 0.68) 15.2 (15.3) 36 0.58 (0.51 to 0.64)
Patient 9 0.6 (0.4) 78 0.87 (0.80 to 0.93) 13.3 (25.1) 36 0.61 (0.55 to 0.67)
Patient 10 2.5 (0.9) 44 0.54 (0.46 to 0.61) 4.2 (1.2) 64 0.60 (0.55 to 0.65)
EA, percentage exact agreement.
*ICC PRISM=0.51 (range 0.32–0.78); ICC PIM=0.18 (range 0.08–0.46).
Table 2 PRISM score based mortality risk; inter-observer agreement by physician category
Residents* (n = 9) Fellows (n = 6) Intensivists` (n = 12)
Mean (SD) EA k scores (95% CI) Mean (SD) EA k scores (95% CI) Mean (SD) EA k scores (95% CI)
Patient 1 2.2 (1.3) 22 0.42 (0.31 to 0.58) 9.6 (13) 0 0.43 (0.27 to 0.68) 4.8 (2.5) 50 0.71 (0.64 to 0.78)
Patient 2 17.0 (24) 0 0.21 (0.11 to 0.34) 27.0 (24) 50 0.57 (0.38 to 0.76) 47.8 (25.1) 50 0.54 (0.42 to 0.72)
Patient 3 0.6 (0.3) 56 0.84 (0.62 to 0.98) 0.5 (0.2) 83 0.84 (0.66 to 0.98) 0.7 (0.2) 66 0.82 (0.72 to 0.91)
Patient 4 1.9 (0.1) 44 0.54 (0.37 to 0.64) 4.5 (4.4) 33 0.39 (0.20 to 0.58) 2.4 (1.2) 50 0.41 (0.30 to 0.51)
Patient 5 0.4 (0.1) 66 0.74 (0.58 to 0.89) 0.4 (0.1) 50 0.62 (0.49 to 0.78) 0.7 (0.4) 78 0.71 (0.64 to 0.77)
Patient 6 2.1 (0.8) 44 0.53 (0.41 to 0.68) 1.8 (0.0) 100 1.00 (0.92 to 1.0) 1.7 (0.3) 89 0.92 (0.83 to 0.96)
Patient 7 4.5 (2.9) 33 0.38 (0.24 to 0.53) 2.5 (1.4) 66 0.58 (0.45 to 0.70) 2.4 (0.9) 44 0.42 (0.32 to 0.51)
Patient 8 20.0 (16.4) 22 0.34 (0.26 to 0.41) 18.1 (15) 33 0.42 (0.29 to 0.55) 17.2 (8.0) 56 0.63 (0.55 to 0.72)
Patient 9 0.8 (0.6) 66 0.59 (0.46 to 0.70) 0.5 (0.0) 83 0.92 (0.80 to 0.99) 0.5 (0.1) 75 0.88 (0.81 to 0.65)
Patient 10 2.1 (0.7) 33 0.52 (0.41 to 0.64) 2.3 (0.7) 50 0.66 (0.51 to 0.80) 2.9 (1.1) 58 0.73 (0.66 to 0.80)
EA, percentage exact agreement.
*ICC residents = 0.24 (range 0.07–0.57);  ICC fellows = 0.40 (range 0.16–0.73); `ICC intensivists = 0.73 (range 0.57–0.91).
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N Pupils can only be scored as fixed when the diameter of
both pupils is .3 mm and when there is no reaction to
light. In addition, the possibility of a medication effect or a
peripheral cause of absent or abnormal pupil reactions as a
direct result of injury to the eyes should be taken into
account. This was not always correctly interpreted.
DISCUSSION
The results of our study show that substantial inter-observer
variability exists in both PRISM and PIM scoring. We had
expected to find some variability on the basis of our
experience in previous studies dealing with the use of the
APACHE II score.7–11 In these studies inter-observer variability
had ranged from 15% to 30%. However, we were quite
surprised by the degree of inconsistency in the use of the PIM
and PRISM scores. Kappa scores ranged from 0.28 to 0.87 in
PRISM scores, and from 0.32 to 0.88 in PIM scores. For the
PRISM score the average ICC was 0.51 (range 0.32–0.78) and
the average kappa score 0.6 (range 0.28–0.87); for the PIM
score the average ICC was 0.18 (range 0.08–0.46) and the
average kappa score 0.53 (range 0.32–0.88). Inter-observer
agreement tended to be better in less severely ill patients. In
this category, the a priori chance of disagreement between
observers is lower due to the fact that there are less abnormal
variables.
Our results contrast with a report by Pollack and
colleagues,6 who studied the effects of variation in frequency
of variable measurements on PRISM scores and found these
effects to be relatively small.6 This study did not deal with the
issue of inter-observer reliability of the measured variables
themselves, which might subsequently affect the scores. Thus
the degree of variability may even have been underestimated
in our study. In addition, errors may have occurred in
different areas of assessment which subsequently ‘‘cancelled
each other out’’; for example, if one observer erroneously
attributed points for chronic diseases while another erro-
neously attributed points for low blood pressure, these two
observers will agree on the total number of points and
predicted mortality; seemingly they are in concurrence, while
in reality their agreement is poor.
Inter-observer variability in PIM scoring appeared higher
than with PRISM scoring, despite the fact that the PIM score
comprises fewer variables. There are several potential
explanations for this observation. Firstly, all variables of the
PIM score are entered directly into the logit equation from
which the mortality risks are calculated, meaning that
differences in the final risk are directly proportionate to
differences in the underlying variable. In addition some
variables of the PIM score carry a relatively high weight,
hence an error in one of these variables will lead to a
relatively large change in the overall score and in predicted
mortality (for example, an erroneous ‘‘specified diagnosis’’).
In PRISM score based mortality risk calculation, all under-
lying variables of acute physiology are added to a single
summary score, which does not reflect that more points that
are attributed to some underlying variables might have been
cancelled out by fewer points that were attributed to other
variables. Only this total number of points (the PRISM score)
is entered in the regression equation (with age and operative
status) to calculate mortality risk, and consequently under-
lying variation in PRISM score variables might be obscured.
Poor agreement in scoring was found in intensivists, PICU
fellows, and residents. The differences between the groups
were unexpectedly small, with experienced physicians
performing only marginally better than inexperienced ones.
In this respect it should be realised that the number of years
of experience in the PICU and/or the age of the physicians
does not necessarily imply dedicated training and regular
checking of the appropriateness of the application of scoring
systems.
Our findings have significant implications. PRISM and
PIM scores are widely used in clinical trials to compare
severity of illness, and for benchmarking and comparison of
quality of care between different PICUs. Our observations
show that inter-observer variability in both scores is of a
magnitude that makes it questionable whether they can, and
should, be used for these purposes when collected in this
way. The results of scoring system assessments, especially
when used in research protocols and as benchmarks for
quality of care, should be unequivocal; this applies especially
when they are used not just by health care providers but also
by hospital managers, insurance companies, and other
financial decision makers, as well as by patient interest
organisations. At the very least a rigorous training pro-
gramme is needed; ideally, patients should probably be
scored by a small number of dedicated, well trained, and
regularly audited staff members.
Our study has a number of potential limitations. Patients
were scored mostly by physicians who were not specifically
trained for scoring, and who worked in different hospitals.
The patient information was presented in the form of copies
of all relevant parts of the medical and nursing charts from
one medical centre; the lack of familiarity with charts from
another hospital might have caused some bias against
physicians working in other centres with different charts.
The situation in daily clinical practice in the participating
centres was as follows: in five participating tertiary PICUs,
patients are normally scored by intensivists and fellows only;
in two centres, residents and nurses also participate in
scoring; and in one centre two dedicated students do the
scoring. Training and auditing are not formally regulated in
any of the eight centres. Although we have not performed a
formal study to assess way the severity of illness scores are
Table 3 PIM Score based mortality risk; inter-observer agreement by physician category
Residents* (n = 9) Fellows (n = 6) Intensivists` (n = 12)
Mean (SD) EA k scores (95% CI) Mean (SD) EA k scores (95% CI) Mean (SD) EA k scores (95% CI)
Patient 1 11.8 (13.7) 15 0.27 (0.22 to 0.39) 7.1 (2.0) 33 0.42 (0.29 to 0.55) 9.6 (5.9) 44 0.48 (0.38 to 0.64)
Patient 2 16.2 (10.7) 56 0.55 (0.41 to 0.68) 39.8 (34.1) 0 0.31 (0.20 to 0.42) 14.2 (6.7) 50 0.51 (0.39 to 0.64)
Patient 3 12.6 (11.1) 66 0.54 (0.42 to 0.67) 20.2 (19.0) 50 0.70 (0.55 to 0.95) 1.0 (0.9) 80 0.74 (0.68 to 0.80)
Patient 4 5.1 (3.4) 22 0.40 (0.36 to 0.48) 13.8 (18.4) 33 0.30 (0.18 to 0.44) 5.1 (2.2) 60 0.56 (0.46 to 0.65)
Patient 5 3.8 (1.9) 44 0.51 (0.39 to 0.66) 2.2 (1.5) 50 0.48 (0.32 to 0.65) 2.3 (1.2) 60 0.62 (0.57 to 0.70)
Patient 6 6.1 (5.3) 33 0.72 (0.59 to 0.87) 4.5 (0.3) 66 0.76 (0.54 to 0.95) 4.2 (0.9) 80 0.82 (0.77 to 0.88)
Patient 7 9.0 (4.4) 33 0.38 (0.30 to 0.48)) 6.5 (5.6) 33 0.36 (0.22 to 0.53) 5.3 (3.6) 30 0.34 (0.25 to 0.44)
Patient 8 22.5 (19.3) 0 0.55 (0.46 to 0.67) 19.3 (18.5) 0 0.41 (0.20 to 0.62) 7.8 (5.6) 30 0.63 (0.54 to 0.72)
Patient 9 7.3 (4.2) 44 0.67 (0.59 to 0.78) 12.1 (16.9) 33 0.62 (0.50 to 0.74) 18.5 (35.8) 40 0.54 (0.43 to 0.65)
Patient 10 4.1 (13.4) 56 0.61 (0.50 to 0.73) 4.8 (13.3) 66 0.58 (0.41 to 0.73) 4.3 (0.6) 70 0.71 (0.64 to 0.80)
EA, percentage exact agreement.
*ICC residents = 0.33 (range 0.14–0.65); ICC fellows = 0.33 (range 0.10–0.69); `ICC = intensivists 0.16 (0.13–0.39).
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collected in most European PICUs, informal inquiries indicate
that circumstances similar to the one in the Netherlands exist
in many other European countries. Therefore, it is highly
likely that our results reflect the average situation in Europe,
although further studies will be required to fully address this
issue.
The situation may be very different in centres were scores
are assessed exclusively by a restricted number of dedicated
staff members (Frank Shann, personal communication). This
method of score collection can be expected to have less inter-
observer variability, although we are not aware of published
studies in which this issue has been addressed. Scores are
collected in this way in many centres in the United States and
Australia, and in some centres in Europe. If this method is
indeed superior, the problem of score collection could in
theory be solved by allowing two or three specially trained
and frequently monitored staff to score patients. However,
this should first be shown in future studies.
Thus, although limiting score collection to a few dedicated
individuals should probably be our long term goal, at this
moment we urgently need to improve the performance of
those currently assessing PIM and PRISM scores. The most
frequent problems in scoring should not be too difficult to
resolve by adequate training and guidelines. These include
using the appropriate time windows, using the appropriate
values (worst in the first 24 hours and first value in the first
hour, respectively), appropriate assessment of GCS and
pupils during use of sedatives, avoiding misinterpretation of
underlying conditions, and inadequate interpretation of the
use of oxygen. Methods through which such a training
programme and strict guidelines can be implemented have
been described previously, in studies where a marked
decrease in inter-observer variability was achieved after a
training programme was implemented.9 With such a pro-
gramme, severity of illness scoring could still be performed by
a relatively large and varying number of (rotating) physi-
cians, or by a small number of well trained and dedicated (for
example, nursing) staff members. The results of our study
suggest that the latter option may be preferable, but it
remains to be determined whether this can be achieved in all
PICUs that use these scoring systems.
In conclusion, we observed wide inter-observer variability
in assessment of PRISM and PIM scores in routine clinical
practice. These scoring systems are widely used in clinical
trials and as instruments to assess and compare quality of
care between different PICUs. In our opinion, based on these
results and in the current situation, the results of these score
assessments should be interpreted with great caution.
Reliability of the scores may be higher if scoring is performed
by a limited number of dedicated individuals, and may be
improved by strict guidelines and regular training. Further
studies are required to address these issues.
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What is already known on this topic
N Severity of illness scoring is used for various purposes
in (paediatric) intensive care
N Reliability has been assessed only in centres closely
involved in their development
N For the APACHE score, used in adult ICUs, substantial
inter-observer variation in routine assessment has been
reported
What this study adds
N In this multicentre study, wide inter-observer variation
in PRISM and PIM based mortality risk was found in
routine clinical practice
N Inter-observer variability could not be explained by the
physicians’ levels of qualification
N Education, training, and guidelines for score assess-
ment are needed, and perhaps severity of illness
scoring in PICUs should be performed only by a limited
number of well trained professionals
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